Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial[J]. J Clin Oncol, 2013,31(4):426-432.
[2]
Peng ZW, Lin XJ, Zhang YJ,et al. Radiofrequency Ablation versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas 2 cm or Smaller: A Retrospective Comparative Study[J]. Radiology, 2012, 262(3):1022-1033
[3]
Inoue T, Kudo M, Hatanaka K,et al. Usefulness of Contrast-Enhanced Ultrasonography to Evaluate the Post-Treatment Responses of Radiofrequency Ablation for Hepatocellular Carcinoma: Comparison with Dynamic CT[J].Oncology,2013,84 :51-57.
[4]
Takaki H, Yamakado K, Nakatsuka A, et al. Frequency of and Risk Factors for Complications After Liver Radiofrequency Ablation Under CT Fluoroscopic Guidance in 1500 Sessions: Single-Center Experience[J].AJR Am J Roentgenol,2013 ,200(3):658-664.
[5]
Mulier S, Ni Y, Jamart J,et al. Local recurrence after hepatic radiofrequency coagulation multivariate meta-analysis and review of contributing factors[J]. Ann Surg, 2005, 242(2): 158-171.
[6]
Kim TJ, Moon WK, Cha JH, et al. VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor[J]. Radiology, 2005, 234: 423-430.
[7]
Goldberg SN, Charboneau JW, Dodd GD,et al. Imaging-guided tumor ablation: proposal for standardization of terms and reporting criteria[J]. Radiology, 2003, 228: 335-345.
